Download
00431_2024_Article_5549.pdf 732,11KB
WeightNameValue
1000 Titel
  • Pulse oximetry signal loss during hypoxic episodes in preterm infants receiving automated oxygen control
1000 Autor/in
  1. Langanky, Lukas O. |
  2. Kreutzer, Karen |
  3. Poets, Christian F. |
  4. Franz, Axel |
  5. Schwarz, Christoph E. |
1000 Verlag Springer Berlin Heidelberg
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-04-09
1000 Erschienen in
1000 Quellenangabe
  • 183(7):2865-2869
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00431-024-05549-9 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11192802/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:p>The aim of this study was to analyze signal loss (SL) resulting from low signal quality of pulse oximetry-derived hemoglobin oxygen saturation (SpO<jats:sub>2</jats:sub>) measurements during prolonged hypoxemic episodes (pHE) in very preterm infants receiving automatic oxygen control (AOC). We did a post hoc analysis of a randomized crossover study of AOC, programmed to set FiO<jats:sub>2</jats:sub> to “back-up FiO<jats:sub>2</jats:sub>” during SL. In 24 preterm infants (median (interquartile range)) gestational age 25.3 (24.6 to 25.6) weeks, recording time 12.7 h (12.2 to 13.6 h) per infant, we identified 76 pHEs (median duration 119 s (86 to 180 s)). In 50 (66%) pHEs, SL occurred for a median duration of 51 s (33 to 85 s) and at a median frequency of 2 (1 to 2) SL-periods per pHE. SpO<jats:sub>2</jats:sub> before and after SL was similar (82% (76 to 88%) vs 82% (76 to 87%), <jats:italic>p</jats:italic> = 0.3)).</jats:p><jats:p><jats:italic>  Conclusion</jats:italic>: SL is common during pHE and must hence be considered in AOC-algorithm designs. Administering a “backup FiO<jats:sub>2</jats:sub>” (which reflects FiO<jats:sub>2</jats:sub>-requirements during normoxemia) during SL may prolong pHE with SL.</jats:p><jats:p><jats:italic>  Trial registration</jats:italic>: The study was registered at <jats:ext-link xmlns:xlink='http://www.w3.org/1999/xlink' ext-link-type='uri' xlink:href='http://www.clinicaltrials.gov'>www.clinicaltrials.gov</jats:ext-link> under the registration no. NCT03785899. <jats:table-wrap><jats:table><jats:tbody> <jats:tr> <jats:td colspan='2'><jats:bold>What is Known:</jats:bold><jats:italic>• Previous studies examined SpO2 signal loss (SL) during routine manual oxygen control being rare, but pronounced in lower SpO2 states.</jats:italic><jats:italic>• Oxygen titration during SL is unlikely to be beneficial as SpO2 may recover to a normoxic range.</jats:italic></jats:td> </jats:tr> <jats:tr> <jats:td colspan='2'><jats:bold>What is New:</jats:bold><jats:italic>• Periods of low signal quality of SpO2 are common during pHEs and while supported with automated oxygen control (SPOC), FiO2 is set to a back-up value reflecting FiO2 requirements during normoxemia in response to SL, although SpO2 remained below target until signal recovery.</jats:italic><jats:italic>• FiO2 overshoots following pHEs were rare during AOC and occurred with a delayed onset; therefore, increased FiO2 during SL does not necessarily lead to overshoots.</jats:italic></jats:td> </jats:tr> </jats:tbody></jats:table></jats:table-wrap></jats:p>
1000 Sacherschließung
lokal Infant, Newborn [MeSH]
lokal Algorithms [MeSH]
lokal Female [MeSH]
lokal Hypoxia/diagnosis [MeSH]
lokal Infant, Premature [MeSH]
lokal Oxygen/blood [MeSH]
lokal Pulse oximetry
lokal Humans [MeSH]
lokal Oxygen Saturation/physiology [MeSH]
lokal Signal loss
lokal Infant, Premature, Diseases/blood [MeSH]
lokal Brief Report
lokal Male [MeSH]
lokal Cross-Over Studies [MeSH]
lokal Oximetry/methods [MeSH]
lokal Hypoxia/blood [MeSH]
lokal Infant, Premature, Diseases/diagnosis [MeSH]
lokal Automated oxygen control
lokal Oxygen Inhalation Therapy/methods [MeSH]
lokal Preterm infant
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TGFuZ2Fua3ksIEx1a2FzIE8u|https://orcid.org/0000-0002-7561-3050|https://orcid.org/0000-0002-1072-0066|https://orcid.org/0000-0001-5066-0857|https://orcid.org/0000-0003-0975-1575
1000 Hinweis
  • DeepGreen-ID: 7b3918de033a4ca2af0c5e7a05676a76 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Universitätsklinikum Heidelberg |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Heidelberg |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6497616.rdf
1000 Erstellt am 2025-02-04T18:17:43.471+0100
1000 Erstellt von 322
1000 beschreibt frl:6497616
1000 Zuletzt bearbeitet 2025-09-14T02:10:31.447+0200
1000 Objekt bearb. Sun Sep 14 02:10:31 CEST 2025
1000 Vgl. frl:6497616
1000 Oai Id
  1. oai:frl.publisso.de:frl:6497616 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source